Hospital resource utilisation from HPV-related diseases in England: a real-world cost analysis

被引:5
|
作者
Fabiano, G. [1 ,2 ]
Marcellusi, A. [1 ,3 ]
Mennini, F. S. [1 ,3 ]
Sciattella, P. [3 ]
Favato, G. [1 ]
机构
[1] Kingston Univ, Inst Leadership & Management Hlth, London, England
[2] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England
[3] Univ Roma Tor Vergata, Fac Econ, Econ Evaluat & HTA EEHTA CEIS, Rome, Italy
来源
EUROPEAN JOURNAL OF HEALTH ECONOMICS | 2023年 / 24卷 / 01期
关键词
Human papillomavirus; Real world; Resource utilization; Hospital episodes statistics; England; GENITAL WARTS; CERVICAL-CANCER; BURDEN; MEN; PREVALENCE; CARE;
D O I
10.1007/s10198-022-01453-x
中图分类号
F [经济];
学科分类号
02 ;
摘要
Background and objective HPV (human papillomavirus) is the virus most often responsible for sexually transmitted infections. The burden of HPV-related diseases on hospital resources represents a major public health problem. The objective of this study was to quantify the lifetime economic burden of HPV-related diseases based on hospital resources from the perspective of National Health Service (NHS) in England. Methods Patients' data were extracted, anonymised and aggregated by NHS digital from Hospital Episode Statistics (HES) database of patients admitted in 2015 and followed for three years. Data on hospitalizations were identified according to the International Classification of Diseases (ICD-10 CM). Health Resource Group (HRG) tariffs and National Reference Costs were used to estimate the hospitalization costs of anal, cervical, genital, oropharyngeal cancers as well as anogenital warts and cervical dysplasia. Results A total of 19,296 hospitalized patients were included in the estimation model, (39% was male and 61% female. At admission, the average age was 60 and 50 years old, respectively). Life-time costs per patients diagnosed with oropharyngeal cancer were 16,911 pound (17,142 pound for male and 16,334 pound for female), penile cancer 12,539 pound, vaginal cancer 12,676 pound, anal cancer 13.773 pound (12,590 pound for male, 14,525 pound for female). Cervical cancer accounted for 12,721 pound, whereas cervical dysplasia for 3932 pound. Resource used for hospitalized patients with anogenital warts was equal to 872 pound (884 pound and 856 pound for men and women, respectively). On average, outpatient accounted for 39% of the total lifetime costs. Conclusion The results of this study highlight that a substantial amount of resources is utilized for the treatment of HPV-related diseases at hospital level in England. These measures have the potential to inform policy decisions to ensure an optimal use of the NHS resources.
引用
收藏
页码:75 / 80
页数:6
相关论文
共 50 条
  • [31] LIFETIME COST ESTIMATION OF HUMAN PAPILLOMAVIRUS RELATED DISEASES IN CHINA: A MODELLING STUDY USING REAL-WORLD DATA
    Ding, W.
    Ma, Y.
    Ma, C.
    Ma, A.
    Tang, W.
    VALUE IN HEALTH, 2021, 24 : S110 - S110
  • [32] Real-world study of multiple sclerosis and related diseases in developing countries
    Han, Jinming
    Carnero Contentti, Edgar
    Liu, Ju
    FRONTIERS IN NEUROLOGY, 2023, 14
  • [33] sFlt-1/PlGF ratio for prediction of preeclampsia in clinical routine: A pragmatic real-world analysis of healthcare resource utilisation
    Dathan-Stumpf, Anne
    Rieger, Anna
    Verlohren, Stefan
    Wolf, Cyrill
    Stepan, Holger
    PLOS ONE, 2022, 17 (02):
  • [34] Cost analysis of reusable gastrointestinal endoscopes in a real-world setting
    Ragunath, K.
    Inoue, M.
    Schmidt, M.
    Rutland, T.
    Tyler, A.
    Hendrie, D.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 278 - 278
  • [35] REAL-WORLD COST-EFFECTIVENESS OF ASFOTASE ALFA FOR TREATMENT OF PATIENTS WITH HPP IN ENGLAND
    Dawson, H.
    OConnell, T.
    Fang, S.
    Kirkwood, K.
    Crowell, M.
    Saraf, Y.
    VALUE IN HEALTH, 2023, 26 (12) : S68 - S68
  • [36] Real-World Effectiveness and Real-World Cost-Effectiveness of Intravitreal Aflibercept and Intravitreal Ranibizumab in Neovascular Age-Related Macular Degeneration: Systematic Review and Meta-Analysis of Real-World Studies
    Carrasco, Joao
    Pietsch, Georg-Alexander
    Nicolas, Marie-Pierre
    Koerber, Cecile
    Bennison, Craig
    Yoon, Jisu
    ADVANCES IN THERAPY, 2020, 37 (01) : 300 - 315
  • [37] REAL-WORLD HEALTH CARE RESOURCE UTILISATION AMONG PATIENTS WITH CHRONIC HEART FAILURE: A CANADIAN ASSESSMENT
    Petrella, R. J.
    Liu, P.
    Chiva-Razavi, S.
    Deschaseaux, C.
    Sagkriotis, A.
    VALUE IN HEALTH, 2014, 17 (03) : A119 - A119
  • [38] Real-World Effectiveness and Real-World Cost-Effectiveness of Intravitreal Aflibercept and Intravitreal Ranibizumab in Neovascular Age-Related Macular Degeneration: Systematic Review and Meta-Analysis of Real-World Studies
    Joao Carrasco
    Georg-Alexander Pietsch
    Marie-Pierre Nicolas
    Cecile Koerber
    Craig Bennison
    Jisu Yoon
    Advances in Therapy, 2020, 37 : 300 - 315
  • [39] Are virtual clinics the future? Real-world data and cost analysis from a UK centre
    Pararajasingam, A.
    Ponnambath, N.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 : 56 - 56
  • [40] The Burden of HPV-Related Hospitalizations: Analysis of Hospital Discharge Records from the Years 2015-2021 from a Southern Italian Region
    Di Martino, Giuseppe
    Cedrone, Fabrizio
    Di Giovanni, Pamela
    Tognaccini, Livia
    Trebbi, Edoardo
    Romano, Ferdinando
    Staniscia, Tommaso
    PATHOGENS, 2023, 12 (05):